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Abstract Pantetheinase is an amidohydrolase involved in the
dissimilative pathway of CoA, allowing the turnover of the
pantothenate moiety. We have determined the N-terminal
sequence as well as the sequences of a number of tryptic and
chymotryptic peptides of the protein isolated from pig kidney.
These sequence stretches were used as probes to search in the
SwissProt database and significant similarities were found with a
GPI-anchored protein (mouse vanin-1, with a suggested role in
lymphocyte migration), with two putative proteins encoded by
human cDNAs (VNN1 and VNN2) and with human biotinidase.
On the basis of sequence similarity, we propose that vanin-1 and
VNN1 should be identified as pantetheinase.
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1. Introduction
Pantetheinase (EC 3.5.1.-, pantetheine hydrolase) hydro-
lyzes speci¢cally one of the carboamide linkages in D-pante-
theine, with the formation of D-pantothenate and cysteamine
[1^6]. The speci¢city of the enzyme is very high for the pan-
tothenate moiety [7], whereas the structure of the cysteamine-
containing part is much less stringent and a thioether group
may substitute for the sulfhydryl group in the substrate [5,8].
Cofactors are not required and a reducing agent (such as
mercaptoethanol or dithiothreitol) must be present for full
activity in vitro.
This hydrolytic activity has been found in many tissues,
such as kidney, liver, heart and muscle of mammals, such as
horse, pig, cattle, rat and cow. High enzyme activity was also
found in the liver of pigeon [9] and other birds [10]. Intra-
cellular distribution studies in rat liver showed its presence
exclusively in the microsomal-lysosomal fraction [5], whereas
in kidney the activity was found also in the soluble fraction
[11].
The pig kidney enzyme has been puri¢ed and enzyme prep-
arations, ranging in activity between 3 and 14 units/mg pro-
tein, show the presence of only one protein band on non-
denaturing and SDS-PAGE and microheterogeneity on iso-
electrofocusing, possibly due to the presence of carbohydrates
[6]. Data on molecular weight, isoelectric point, amino acid
and carbohydrate content and other properties of proteins of
di¡erent origin have been published [2,5]. Details on kinetic
and catalytic features of the horse kidney enzyme [2,3], on
inhibition patterns by disul¢des [12,13], on the stability of
the molecule and the £exibility of the active site of the pig
kidney enzyme [14,15] were also reported.
The enzyme has a role in the dissimilative pathway of CoA
and acyl carrier proteins, allowing the turnover of the pan-
tothenate moiety. It seems to be also involved in metabolic
pathways leading to taurine. In connection with pantotheno-
yl-4P-phosphate-L-cysteine decarboxylase (EC 4.1.1.36), pante-
theinase has a role in the metabolic route that converts cys-
teine, with cysteamine and hypotaurine as intermediates, to
taurine in those tissues (as heart or brain) where the main
route, involving cysteine sul¢nic acid decarboxylase (EC
4.1.1.29), is less e⁄cient or absent [16,17]. A role in the bio-
synthesis of S-aminoethyl-L-cysteine and S-aminoethyl-L-cys-
teine ketimine has also been demonstrated in vitro [18,19].
Recently, ‘prebiotic’ synthesis of pantetheine has been dem-
onstrated to occur in vitro under mild conditions, from a
mixture of L-alanine, pantoyl lactone and cysteamine; all
these reagents are supposed to be prebiotic compounds [20].
It has been suggested that pantetheine could have been im-
portant in the earliest metabolic systems for the so-called
‘thioester world’, which could have preceded the RNA world.
In this context, pantetheinase could be considered as a pace-
maker enzyme dictating the turnover rate of pantetheine, its
activity being of great importance for maintaining a suitable
concentration of an indispensable coenzyme. Thus, it would
not be surprising if the sequence of this enzyme, as observed
for other important proteins, would be largely conserved
throughout living organisms. Furthermore, it is expected
that an early enzyme has a large di¡usion and possess a rather
stable tertiary structure. In fact, pig kidney pantetheinase
shows a thermal resistance unusual for mammalian enzymes
[15], the overall structure seems to be formed by a very resist-
ant external cage and a more £exible internal core where the
active site is located [14].
The human enzyme has never been isolated, although pan-
tetheinase activity has been observed in human cells (leuko-
cytes, ¢broblasts, intestine cells) and in plasma [10,21,22]. A
protein cross-reacting with an anti-pantetheinase antibody has
been detected in human plasma (G. Pitari, personal commu-
nication).
In this paper we report the partial sequence of the pig
kidney enzyme, as determined following isolation and se-
quencing of a number of tryptic and chymotryptic peptides.
Furthermore, on the basis of sequence similarities, we propose
that mouse vanin-1 [23] and human VNN1 [24] could be iden-
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ti¢ed as pantetheinase and suggest to the Enzyme Commission
the assignment of a speci¢c EC number to this enzyme.
2. Materials and methods
2.1. Chemicals
Trypsin and chymotrypsin were from Worthington; iodo-
[2-14C]acetate from The Radiochemical Centre, Amersham, UK; gua-
nidinium chloride (recrystallized from methanol) from Merck. HPLC-
grade solvents were from Carlo Erba; sequence-grade chemicals from
Perkin-Elmer.
2.2. Puri¢cation of pantetheinase
Pig kidney pantetheinase was puri¢ed according to [5]. Pantethei-
nase activity was determined according to [25] with pantetheine S-
pyruvate as substrate, after reduction of the enzyme with mercapto-
ethanol and ¢ltration through Sephadex G-25 to remove the excess.
Protein concentration was determined using E1% = 11.3 (280 nm) as
extinction coe⁄cient [5]. The puri¢ed protein was subjected to SDS-
PAGE by the Laemmli method [26] at 10% acrylamide (Miniprotean,
Bio-Rad) and stained both with Coomassie blue and silver stain and
to isoelectric focusing on precasted Ampholine PAG plates, pH 3.5^
9.5 (Pharmacia LKB Biotechnology), following the manufacturer’s
instructions; proteins were located by silver staining.
2.3. Enzymatic cleavage of pantetheinase
The puri¢ed protein (1 mg) was carboxymethylated with iodo-
[2-14C]acetate, dialyzed against water, lyophilized, suspended in 0.5 ml
of 0.1 M ammonium bicarbonate and incubated at 37‡C for 3 h after
addition of 30 Wg trypsin. A second sample (0.5 mg) was treated as
before and digested with 10 Wg chymotrypsin in the same conditions.
2.4. Peptide puri¢cation and analytical techniques
Tryptic and chymotryptic peptides were puri¢ed using a Beckman
System Gold chromatograph on a reversed-phase column (Vydac C8,
4.6U250 mm, 7 Wm). Peptides were eluted with a linear gradient of
0 to 50% acetonitrile in 0.2% (v/v) tri£uoroacetic acid at a £ow rate of
1.0 ml/min. Elution of peptides was monitored using a diode array
detector (Beckman model 168) at 220 and 280 nm.
The amino acid sequence of the carboxymethylated protein and
proteolytic fragments was determined by automated Edman degrada-
tion using a Perkin-Elmer model AB476A sequencer. Samples (0.1^0.3
nmol) were loaded onto a polyvinylidene di£uoride membrane (Pro-
blott, Perkin-Elmer) coated with 2 Wl polybrene (20 mg/ml of 70%
methanol).
2.5. Database searches
Similarity searches in the SwissProt database as well as searches in
the expressed sequence tags database (dbEST) were performed using
the Basic Local Alignment Search Tool (BLAST) algorithm from the
National Center of Biotechnology Information (NCBI). Sequence
alignment was performed by the MULTALIN program [27]. All other
tools were from the ExPASy Molecular Biology Server.
3. Results and discussion
Pantetheinase puri¢ed from pig kidney, with a speci¢c ac-
tivity of about 3 U/mg, was homogeneous on SDS-PAGE
giving a single band at about 58 kDa. Isoelectrofocusing in
the pH range 3^11 shows some microheterogeneity, which
disappears after treatment with neuroaminidase. This behav-
ior has been observed with many glycoproteins and may de-
pend on di¡erent hydrolysis stages of the carbohydrate moiety
of the protein. In fact, the sugar content of pantetheinase has
been reported to be about 10% [6].
From the tryptic and chymotryptic digests of pig pantethei-
nase, several peptides were isolated and sequenced. The se-
quences of these peptides as well as the N-terminal sequence
of the native protein were used as probes to search in the
SwissProt database. Signi¢cant similarities were found with
the putative proteins encoded by two human cDNAs, called
VNN1 and VNN2 [24], and with a related mouse protein,
vanin-1 [23]. The latter has been isolated from thymic peri-
cytes and seems to be involved in lymphocyte migration [23].
VNN1 and VNN2 are located on chromosome 6q23-q24,
whose mutations are involved in invasivity of metastasis in
human cancer [24]. Recently, a glycosylphosphatidyl-inositol
(GPI)-anchored protein from human leukocytes (termed GPI-
80) has been described with a suggested role in the regulation
of neutrophil adherence and migration [28]. This sequence is
identical to that of VNN2.
The peptides isolated and characterized from the pig en-
zyme presumably account for about 64% of the whole protein
sequence, assuming a length similar to that of vanins. We
judged that this sequence information was su⁄cient to sup-
port the conclusions presented in this paper. Therefore, no
e¡ort was spent to complete the primary structure of the
enzyme.
The peptides could be easily aligned to the corresponding
regions of both mouse and human vanins (Fig. 1). Pairwise
comparison of the sequences reported in Fig. 1 shows di¡erent
levels of similarity (Table 1). The degree of similarity of pan-
tetheinase to mouse vanin-1 or human VNN1 is higher (79.7
or 83.2% identity, respectively) than to VNN2 (65.2%). The
percentage identity between mouse vanin-1 and human VNN1
is 79.1%, whereas the similarity between the two and VNN2
ranges around 63% identity.
As shown in Table 1, human and murine vanin proteins
share 40% sequence identities with human biotinidase [29].
The latter enzyme catalyzes the hydrolysis of biocytin, the
degradation product of biotin-dependent carboxylases, lead-
ing to free biotin and lysine, a reaction similar to that cata-
lyzed by pantetheinase. Although no biotinidase activity was
found associated to vanin-1 [23], the authors suggest that all
these proteins belong to a new family of related molecules.
The comparison between pig pantetheinase and human bio-
tinidase shows 46.5% identity. Although these are only partial
data, it is possible to speculate that pantetheinase and vanin-
1/VNN1, that share the greatest similarity, are highly related
proteins, both di¡erent from VNN2. In this view, mouse and
human vanin-1 can be actually identi¢ed as pantetheinase,
while human VNN2 and biotinidase can be considered related
proteins belonging to the same amidohydrolase family with
di¡erent substrate speci¢city.
Table 1
Sequence identities among amidohydrolases
Mouse vanin-1 Human VNN1 Human VNN2 Human biotinidase
%
Pig pantetheinase 79.7 83.2 65.2 46.5
Mouse vanin-1 79.1 63.6 42.0
Human VNN1 63.7 42.7
Human VNN2 39.1
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To con¢rm this hypothesis, the sequence of human pante-
theinase should be determined. However, by exploiting avail-
able sequence information, further evidence in favor of the
proposed identi¢cation may be presented.
In fact, when the sequences of the peptides of the pig pro-
tein were translated, using the algorithm available among the
Swiss-Prot tools, into the corresponding nucleotide sequences,
and the latter were used to search in the EST database, some
human and mouse cDNAs were retrieved with signi¢cant
scores. The sequences of the retrieved human clones were
then translated according to the correct reading frame and
this provided more extended sequence information. These
amino acid sequences in all cases matched only the sequences
of vanin-1/VNN1 and VNN2, indicating that no other related
proteins are present in the database. This further supports the
proposed identity between VNN1 and pantetheinase.
The N-terminal sequence of the pig enzyme was directly
determined by automatic Edman degradation of the native
protein and it is similar to that found for vanin-1 and GPI-
80 (VNN2). Because of the similarities between the mamma-
lian protein precursors, we assumed also for VNN1 a similar
processing leading to the removal of the signal sequence.
Therefore, this extension is not reported in Fig. 1. For bio-
tinidase, the ¢rst 10 residues of the putative protein [29] are
not reported in Fig. 1
Both vanin-1 and GPI-80 (VNN2) are GPI-anchored pro-
Fig. 1. Amino acid sequence comparison among amidohydrolases. BTD, human biotinidase [29] ; VNN1 and VNN2, putative proteins deduced
from human cDNAs [24]; V-1, mouse vanin-1 [23] ; pant, pig kidney pantetheinase (this paper). Gaps (.) have been inserted to maximize the
identities among the four sequences (marked by the asterisks). The ¢rst 10 residues of biotinidase are not included. The numbering is given
starting from the ¢rst compared amino acid position. VNN2 is identical to GPI-80 [28].
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teins [23,28], sharing with VNN1 the C-terminus consensus
GPI cleavage site (position 504^508 in Fig. 1). In this region
we lack sequence information. However, some properties of
pig kidney pantetheinase indicate that it is a hydrophobic
protein, being extracted with butanol and puri¢ed on octyl-
Sepharose. Furthermore, preliminary experiments on human
leukocytes show that pantetheinase activity is detected in
supernatants of plasma membranes only after treatment
with phospholipase C. A speci¢c activity of about 2.0 nmol
of pantetheine/min/mg protein was calculated.
Another feature shared between pantetheinase and vanin-1
is the presence of carbohydrates, as detected following neuro-
aminidase digestion [23] (see above).
It is worth noting that using either VNN1 or VNN2 se-
quences as probes no signi¢cant matches with other known
proteins in the database can be retrieved, despite the fact that
complete genomes are now available. This is somehow unex-
pected, since pantetheinase should be a very ancient protein
and pantetheine is considered an old cofactor shared by al-
most all known organisms.
The data so far available do not allow any obvious corre-
lation between lymphocyte migration and pantetheine metab-
olism. Further studies will provide insights into the relation-
ship among these proteins.
During the publication processing of this manuscript, a
paper on Immunogenetics became available on PubMed at
the National Center for Biotechnology Information [30].
The authors present results obtained by computational anal-
ysis of EST sequence database resources, which are available
at the web site http://tagc.univ-mrs.fr/pub/vanin/ and suggest
that vanin molecules might bear an enzymatic activity.
The evidence we present in this paper may be crucial in the
assignment of a function to this protein family.
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